Evidence
Microb Biotechnol. 2024 Apr;17(4):e14462. doi: 10.1111/1751-7915.14462.
ABSTRACT
Alzheimer’s disease is a complex and progressive condition that affects essential neurological functions such as memory and reasoning. In the brain, neuronal loss, synaptic dysfunction, proteinopathy, neurofibrillary tangles, and neuroinflammation are the hallmarks of Alzheimer’s disease pathophysiology. In addition, recent evidence has highlighted that microbes, whether commensal or pathogenic, also have the ability to interact with their host and to regulate its immune system, therefore participating in the exchanges that lead to peripheral inflammation and neuropathology. Because of this intimate relationship, bacteria, viruses, fungi, and protozoa have been implicated in the development of Alzheimer’s disease. Here, we bring together current and most recent evidence of the role of microbes in Alzheimer’s disease, raising burning questions that need to be addressed to guide therapeutic approaches and potential prophylactic strategies.
PMID:38593310 | DOI:10.1111/1751-7915.14462
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Do microbes play a role in Alzheimer’s disease?
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- P2Y1 receptor in Alzheimer's disease
- The vascular contribution of apolipoprotein E to Alzheimer's disease
- Systemic inflammation in Ab1-40-induced Alzheimer's disease model: New translational opportunities
- Generating PET scan patterns in Alzheimer's by a mathematical model
- Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- Adaptive immune changes associate with clinical progression of Alzheimer's disease
- Genomic stress and impaired DNA repair in Alzheimer disease
- The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
- Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
- Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke
- Innate immune activation in neurodegenerative diseases
- An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature
- The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature
- Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
- Utility of zebrafish-based models in understanding molecular mechanisms of neurotoxicity mediated by the gut-brain axis
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
- Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
- Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer's disease
- Association between hypothalamic Alzheimer's disease pathology and body mass index: The Hisayama study
- Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Rejuvenation of peripheral immune cells attenuates Alzheimer's disease-like pathologies and behavioral deficits in a mouse model
- Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
- The complement system in neurodegenerative diseases
- Sonic Hedgehog Signalling Pathway Contributes in Age-Related Disorders and Alzheimer's Disease
- Hypoxia inducible factor-1a regulates microglial innate immune memory and the pathology of Parkinson's disease
- Multiple system atrophy with amyloid-b-predominant Alzheimer's disease neuropathologic change
- Interleukins in liver disease treatment
- Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seq
- Towards cascading genetic risk in Alzheimer's disease
- Evaluation of altered cell-cell communication between glia and neurons in the hippocampus of 3xTg-AD mice at two time points
- Sleep disruption precedes forebrain synaptic Tau burden and contributes to cognitive decline in a sex-dependent manner in the P301S Tau transgenic mouse model
- Benefits of Music Therapy in the Cognitive Impairments of Alzheimer's-Type Dementia: A Systematic Review
- Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia
- The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review
- Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease
- Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases
- Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks
- Effects of tooth loss on behavioral and psychological symptoms of dementia in app knock-in mice
- The immune system in Parkinson's disease: what we know so far
- Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems
- Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis
- Cerebral malaria pathogenesis: Dissecting the role of CD4+ and CD8+ T-cells as major effectors in disease pathology
- Assessing translational applicability of perineuronal net dysfunction in Alzheimer's disease across species
- Loss of GDE2 leads to complex behavioral changes including memory impairment
- Reduced STMN2 and pathogenic TDP-43, two hallmarks of ALS, synergize to accelerate motor decline in mice
- Brain hypothyroidism silences the immune response of microglia in Alzheimer's disease animal model
- Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence
- Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis
- Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease
- A Comprehensive Review and Androgen Deprivation Therapy and Its Impact on Alzheimer's Disease Risk in Older Men with Prostate Cancer
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Profiling of long non-coding RNAs in hippocampal-entorhinal system subfields: impact of RN7SL1 on neuroimmune response modulation in Alzheimer's disease
- Exploring morphological similarity and randomness in Alzheimer's disease using adjacent grey matter voxel-based structural analysis
- Current and further outlook on the protective potential of Antrodia camphorata against neurological disorders
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- Cross-regulation between the immune system and the extracellular matrix during lung pathology
Evidence Blueprint
Do microbes play a role in Alzheimer’s disease?
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Do microbes play a role in Alzheimer’s disease?
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- P2Y1 receptor in Alzheimer's disease
- Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
- The vascular contribution of apolipoprotein E to Alzheimer's disease
- Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases
- Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases
- Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells
- Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease
- Acetobacter pasteurianus BP2201 alleviates alcohol-induced hepatic and neuro-toxicity and modulate gut microbiota in mice
- Porphyromonas gingivalis, neuroinflammation and Alzheimer's disease
- Systemic inflammation in Ab1-40-induced Alzheimer's disease model: New translational opportunities
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Deregulation of the Glymphatic System in Alzheimer's Disease: Genetic and Non-Genetic Factors
- TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA
- Translocation of gut commensal bacteria to the brain
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview
- Amidst an amygdala renaissance in Alzheimer's disease
- UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS
- Generating PET scan patterns in Alzheimer's by a mathematical model
- Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
- Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease
- Lipids and lipoproteins may play a role in the neuropathology of Alzheimer's disease
- Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease
- Microglial regulation of brain function and pathological changes
- Adaptive immune changes associate with clinical progression of Alzheimer's disease
- Genomic stress and impaired DNA repair in Alzheimer disease
- N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease
- A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity
- Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease
- The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner
- Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients
- The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
- Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two
- Decoding metabolic signatures in Alzheimer's disease: a mitochondrial perspective
- Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer's Disease Pathogenesis
- Advances in nanoprobes for molecular MRI of Alzheimer's disease
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease
- GABA-Transaminase: A Key Player and Potential Therapeutic Target for Neurological Disorders
- Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease
- The elusive role of herpesviruses in Alzheimer's disease: current evidence and future directions
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- Hotspots and trends of microglia in Alzheimer's disease: a bibliometric analysis during 2000-2022
- Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease
- Biomarkers associated with the pathogenesis of Alzheimer's disease
- Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders
- The Role of RIN3 Gene in Alzheimer's Disease Pathogenesis: a Comprehensive Review
- Neuropathology of Alzheimer's Disease
- T lymphocytes in the pathogenesis and progression of Alzheimer's disease: pursuing direct neuropathological evidence
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease
- Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases
- Dysregulated glial genes in Alzheimer's disease are essential for homeostatic plasticity: Evidence from integrative epigenetic and single cell analyses
- Pathophysiology of dementia
- Blood-brain barrier pathology in cerebral small vessel disease
- Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke
- Is Alzheimer disease a disease?
- Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid beta